Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study
- PMID: 31334907
- PMCID: PMC8051186
- DOI: 10.1111/1471-0528.15885
Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study
Abstract
Objective: To evaluate the association between marijuana use and a composite adverse pregnancy outcome using biological sampling.
Design: Retrospective cohort study.
Setting: Single tertiary center.
Population: Young women (13-22 years old) with singleton, non-anomalous pregnancies delivered from September 2011 to May 2017.
Methods: Exposure was defined as marijuana detected on universal urine toxicology testing or by self-report. Multivariable logistic regression modelling was used to estimate the effect of any marijuana use on the primary composite outcome. The effect of marijuana exposure was also estimated for self-reported use, toxicology-detected use, and multiple use detected by toxicology.
Main outcome measure: The primary composite outcome included spontaneous preterm birth, hypertensive disorders of pregnancy, stillbirth, or small for gestational age.
Results: Of 1206 pregnant young women, 17.5% (n = 211) used marijuana. Among the women who used marijuana, 8.5% (n = 18) were identified by self-report alone, 63% (n = 133) by urine toxicology alone, and 28.4% (n = 60) by both. Urine toxicology testing results were available for 1092 (90.5%) births. The composite outcome occurred more frequently in pregnancies exposed to marijuana (46 versus 34%, P < 0.001). This remained significant after adjusting for race/ethnicity and tobacco in the multivariable model (adjusted OR 1.50, 95% CI 1.09-2.05). When marijuana exposure was defined by self-report only, the association with adverse pregnancy outcome became non-significant (adjusted OR 1.01, 95% CI 0.62-1.64).
Conclusion: In a population of young women with nearly universal biological sampling, marijuana exposure was associated with adverse pregnancy outcomes. The heterogeneity of findings in existing studies evaluating the impact of marijuana on mothers and neonates may result from the incomplete ascertainment of exposure.
Tweetable abstract: Marijuana use, as detected by universal urine testing, was associated with a composite adverse pregnancy outcome among young mothers.
Keywords: THC; Cannabis; hypertensive disorders of pregnancy; marijuana; pregnancy; preterm birth; small for gestational age; stillbirth.
© 2019 Royal College of Obstetricians and Gynaecologists.
Conflict of interest statement
Disclosure of Interests:
The authors report no conflict of interest. Completed disclosure of interest forms are available to view online as supporting information.
Figures
Comment in
-
Marijuana use among young pregnant women: more common and more harmful than we think.BJOG. 2019 Nov;126(12):1498. doi: 10.1111/1471-0528.15919. Epub 2019 Sep 18. BJOG. 2019. PMID: 31454457 No abstract available.
Similar articles
-
Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.Am J Obstet Gynecol. 2017 Oct;217(4):478.e1-478.e8. doi: 10.1016/j.ajog.2017.05.050. Epub 2017 May 31. Am J Obstet Gynecol. 2017. PMID: 28578174 Free PMC article.
-
Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Jan 4;5(1):e2145653. doi: 10.1001/jamanetworkopen.2021.45653. JAMA Netw Open. 2022. PMID: 35084479 Free PMC article.
-
Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function.JAMA. 2023 Dec 12;330(22):2191-2199. doi: 10.1001/jama.2023.21146. JAMA. 2023. PMID: 38085313 Free PMC article.
-
Marijuana use in opioid exposed pregnancy increases risk of preterm birth.J Matern Fetal Neonatal Med. 2022 Dec;35(25):8456-8461. doi: 10.1080/14767058.2021.1980532. Epub 2021 Sep 28. J Matern Fetal Neonatal Med. 2022. PMID: 34582287
-
Risk of stillbirth, preterm delivery, and fetal growth restriction following exposure in a previous birth: systematic review and meta-analysis.BJOG. 2018 Jan;125(2):183-192. doi: 10.1111/1471-0528.14906. Epub 2017 Oct 3. BJOG. 2018. PMID: 28856792
Cited by
-
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy.J Addict Med. 2025 Mar 3:10.1097/ADM.0000000000001454. doi: 10.1097/ADM.0000000000001454. Online ahead of print. J Addict Med. 2025. PMID: 40028912
-
Risk Perceptions about Cannabis Use and Receipt of Health-Related Information during Pregnancy.Am J Health Promot. 2022 Nov;36(8):1316-1325. doi: 10.1177/08901171221099496. Epub 2022 May 5. Am J Health Promot. 2022. PMID: 35512115 Free PMC article.
-
Women's Experiences with Nicotine and Cannabis Vaping During Pregnancy and Postpartum.Healthcare (Basel). 2025 Jan 22;13(3):223. doi: 10.3390/healthcare13030223. Healthcare (Basel). 2025. PMID: 39942412 Free PMC article.
-
Disparities in Healthcare Providers' Substance Use Detection Practices for Pregnant Patients.J Racial Ethn Health Disparities. 2025 Jun 27. doi: 10.1007/s40615-025-02523-5. Online ahead of print. J Racial Ethn Health Disparities. 2025. PMID: 40579635
-
Quantification of prenatal marijuana use: evaluation of the correlation between self-report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals.Addiction. 2022 Jan;117(1):172-181. doi: 10.1111/add.15606. Epub 2021 Jun 28. Addiction. 2022. PMID: 34142398 Free PMC article.
References
-
- Committee on Obstetric P. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics and gynecology. 2017;130(4):e205–e9. - PubMed
-
- Metz TD, Stickrath EH. Marijuana Use in Pregnancy and Lactation: A Review of the Evidence. American journal of obstetrics and gynecology. 2015. - PubMed
-
- Burns L, Mattick RP, Cooke M. The use of record linkage to examine illicit drug use in pregnancy. Addiction. 2006;101(6):873–82. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical